» Articles » PMID: 3624443

Production of Toxic Shock Syndrome Toxin 1 by Staphylococcus Aureus Restricted to Endogenous Air in Tampons

Overview
Specialty Microbiology
Date 1987 Aug 1
PMID 3624443
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

All types of four brands of tampons were tested in triplicate by a tampon sac method for their effect on production of toxic shock syndrome toxin 1 (TSST-1). In this method the available air is limited to that which is in the tampon sac. Tampons were weighed and inserted into dialysis sacs inoculated with a TSST-1-producing Staphylococcus aureus strain; the sacs were submerged into brain heart infusion agar, which was allowed to harden around the sacs, and were incubated for 18 h at 37 degrees C. The tampons were removed, weighed, and extracted; the CFU of staphylococci and the amount of toxin present in the extracts were determined. Glass wool was used in place of the tampons as one control, and inoculated empty sacs were used as a second control. The total CFU were consistently greater than 2 X 10(11) for the tampons and glass wool and less than or equal to 10(11) for the empty sac control. Total toxin production for all tampons tested and the glass wool was 2 to 10 times higher than the toxin produced with the empty sac control. These results indicate that tampons provide increased surface area for the staphylococci to grow and adequate oxygen for toxin production. No significant inhibition of growth of the staphylococci or TSST-1 production by any of the tampons tested was noted.

Citing Articles

Development of methods to model the impact of vaginal lactobacilli on biofilm formation on menstrual cups as well as validation of recommended cleaning directions.

Friberg M, Woeller K, Iberi V, Mancheno P, Riedeman J, Bohman L Front Reprod Health. 2023; 5:1162746.

PMID: 37671283 PMC: 10475951. DOI: 10.3389/frph.2023.1162746.


The safety assessment of tampons: illustration of a comprehensive approach for four different products.

Hochwalt A, Abbinante-Nissen J, Bohman L, Hattersley A, Hu P, Streicher-Scott J Front Reprod Health. 2023; 5:1167868.

PMID: 37408999 PMC: 10319135. DOI: 10.3389/frph.2023.1167868.


Device-Associated Menstrual Toxic Shock Syndrome.

Schlievert P, Davis C Clin Microbiol Rev. 2020; 33(3).

PMID: 32461307 PMC: 7254860. DOI: 10.1128/CMR.00032-19.


Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production .

Nonfoux L, Chiaruzzi M, Badiou C, Baude J, Tristan A, Thioulouse J Appl Environ Microbiol. 2018; 84(12).

PMID: 29678918 PMC: 5981080. DOI: 10.1128/AEM.00351-18.


Examining the safety of menstrual cups among rural primary school girls in western Kenya: observational studies nested in a randomised controlled feasibility study.

Juma J, Nyothach E, Laserson K, Oduor C, Arita L, Ouma C BMJ Open. 2017; 7(4):e015429.

PMID: 28473520 PMC: 5566618. DOI: 10.1136/bmjopen-2016-015429.


References
1.
Crass B, Bergdoll M . Toxin involvement in toxic shock syndrome. J Infect Dis. 1986; 153(5):918-26. DOI: 10.1093/infdis/153.5.918. View

2.
Lee A, Crass B, Bergdoll M . Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus. J Clin Microbiol. 1987; 25(1):87-90. PMC: 265830. DOI: 10.1128/jcm.25.1.87-90.1987. View

3.
Schlievert P, Blomster D, Kelly J . Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Obstet Gynecol. 1984; 64(5):666-71. View

4.
Tierno Jr P, Hanna B . In vitro amplification of toxic shock syndrome toxin-1 by intravaginal devices. Contraception. 1985; 31(2):185-94. DOI: 10.1016/0010-7824(85)90033-2. View

5.
Osterholm M, Davis J, Gibson R, Mandel J, Wintermeyer L, Helms C . Tri-state toxic-state syndrome study. I. Epidemiologic findings. J Infect Dis. 1982; 145(4):431-40. DOI: 10.1093/infdis/145.4.431. View